tokens: CONCLUSION : Treatment of sepsis with the platelet activating factor antagonist BB-882 offers no advantage over placebo on survival , hemodynamic status , respiratory function , or organ failure scores .
folded_tokens: conclusion : treatment of sepsis with the platelet activate factor antagonist bb-882 offer no advantage over placebo on survival , hemodynamic status , respiratory function , or organ failure score .